1 Masuzaki H, "Transgenic amplification of glucocorticoid action in adipose tissue causes high blood pressure in mice" 112 : 83-90, 2003
2 Rask E, "Tissue-specific dysregulation of cortisol metabolism in human obesity" 86 : 1418-1421, 2001
3 윤영숙, "The new definition of metabolic syndrome by the international diabetes federation is less likely to identify metabolically abnormal but non-obese individuals than the definition by the revised national cholesterol education program: The Korea NHANES Study" NATURE PUBLISHING GROUP 31 : 528-534, 200703
4 Reaven G, "The metabolic syndrome or the insulin resistance syndrome? Different names, different concepts, and different goals" 33 : 283-303, 2004
5 Pasquali R, "The hypothalamic-pituitaryadrenal axis in obese women with different patterns of body fat distribution" 77 : 341-346, 1993
6 Pasquali R, "The hypothalamic- pituitary-adrenal axis activity in obesity and the metabolic syndrome" 1083 : 111-128, 2006
7 Tomlinson JW, "The functional consequences of11beta-hydroxysteroid dehydrogenase expression in adiposetissue" 34 : 746-751, 2002
8 Nieman LK, "The diagnosis of Cushing’s syndrome: an Endocrine Society Clinical Practice Guideline" 93 : 1526-1540, 2008
9 장윤미, "The Association between Midnight Salivary Cortisol and Metabolic Syndrome in Korean Adults" 대한당뇨병학회 36 (36): 245-250, 2012
10 Epel ES, "Stress and body shape: stressinduced cortisol secretion is consistently greater among women with central fat" 62 : 623-632, 2000
1 Masuzaki H, "Transgenic amplification of glucocorticoid action in adipose tissue causes high blood pressure in mice" 112 : 83-90, 2003
2 Rask E, "Tissue-specific dysregulation of cortisol metabolism in human obesity" 86 : 1418-1421, 2001
3 윤영숙, "The new definition of metabolic syndrome by the international diabetes federation is less likely to identify metabolically abnormal but non-obese individuals than the definition by the revised national cholesterol education program: The Korea NHANES Study" NATURE PUBLISHING GROUP 31 : 528-534, 200703
4 Reaven G, "The metabolic syndrome or the insulin resistance syndrome? Different names, different concepts, and different goals" 33 : 283-303, 2004
5 Pasquali R, "The hypothalamic-pituitaryadrenal axis in obese women with different patterns of body fat distribution" 77 : 341-346, 1993
6 Pasquali R, "The hypothalamic- pituitary-adrenal axis activity in obesity and the metabolic syndrome" 1083 : 111-128, 2006
7 Tomlinson JW, "The functional consequences of11beta-hydroxysteroid dehydrogenase expression in adiposetissue" 34 : 746-751, 2002
8 Nieman LK, "The diagnosis of Cushing’s syndrome: an Endocrine Society Clinical Practice Guideline" 93 : 1526-1540, 2008
9 장윤미, "The Association between Midnight Salivary Cortisol and Metabolic Syndrome in Korean Adults" 대한당뇨병학회 36 (36): 245-250, 2012
10 Epel ES, "Stress and body shape: stressinduced cortisol secretion is consistently greater among women with central fat" 62 : 623-632, 2000
11 Kahn JP, "Salivary cortisol: a practical method for evaluation of adrenal function" 23 : 335-349, 1988
12 Mai K, "Rosiglitazone decreases 11beta-hydroxysteroid dehydrogenase type 1 in subcutaneous adipose tissue" 67 : 419-425, 2007
13 오상우, "Obesity and Metabolic Syndrome in Korea" 대한당뇨병학회 35 (35): 561-566, 2011
14 Alexandraki KI, "Novel insights in the diagnosis of Cushing’s syndrome" 92 (92): 35-43, 2010
15 Morton NM, "Novel adipose tissue-mediated resistance to diet-induced visceral obesity in 11 beta-hydroxysteroid dehydrogenase type 1-deficient mice" 53 : 931-938, 2004
16 Wilson PW, "Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus" 112 : 3066-3072, 2005
17 Wake DJ, "Local and systemic impact of transcriptional up-regulation of 11beta-hydroxysteroid dehydrogenase type 1 in adipose tissue in human obesity" 88 : 3983-3988, 2003
18 Duclos M, "Increased cortisol bioavailability, abdominal obesity, and the metabolic syndrome in obese women" 13 : 1157-1166, 2005
19 Pasquali R, "Hypothalamic- pituitary-adrenal axis activity and its relationship to the autonomic nervous system in women with visceral and subcutaneous obesity: effects of the corticotropin-releasing factor/arginine- vasopressin test and of stress" 45 : 351-356, 1996
20 Duclos M, "Fat distribution in obese women is associated with subtle alterations of the hypothalamic-pituitary-adrenal axis activity and sensitivity to glucocorticoids" 55 : 447-454, 2001
21 Phillips DI, "Elevated plasma cortisol concentrations: a link between low birth weight and the insulin resistance syndrome?" 83 : 757-760, 1998
22 Andrews RC, "Effects of the 11betahydroxysteroid dehydrogenase inhibitor carbenoxolone on insulin sensitivity in men with type 2 diabetes" 88 : 285-291, 2003
23 Bujalska IJ, "Does central obesity reflect“Cushing’s disease of the omentum”?" 349 : 1210-1213, 1997
24 Grundy SM, "Diagnosis and management of the metabolic syndrome: an American Heart Association/ National Heart, Lung, and Blood Institute Scientific Statement" 112 : 2735-2752, 2005
25 Walker BR, "Cortisol: cause and cure for metabolic syndrome?" 23 : 1281-1288, 2006
26 Marin P, "Cortisol secretion in relation to body fat distribution in obese premenopausal women" 41 : 882-886, 1992
27 Travison TG, "Cortisol levels and measures of body composition in middle-aged and older men" 67 : 71-77, 2007
28 Anagnostis P, "Clinical review: the pathogenetic role of cortisol in the metabolic syndrome: a hypothesis" 94 : 2692-2701, 2009
29 Sen Y, "Children and adolescents with obesity and the metabolic syndrome have high circulating cortisol levels" 29 : 141-145, 2008
30 DeSantis AS, "Associations of salivary cortisol levels with metabolic syndrome and its components: the multi-ethnic study of atherosclerosis" 96 : 3483-3492, 2011
31 Weigensberg MJ, "Association between the metabolic syndrome and serum cortisol in overweight Latino youth" 93 : 1372-1378, 2008
32 Pasquali R, "Activity of the hypothalamic-pituitaryadrenal axis in different obesity phenotypes" 24 (24): S47-S49, 2000
33 Zimmet P, "A new international diabetes federation worldwide definition of the metabolic syndrome: the rationale and the results" 58 : 1371-1376, 2005